Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
Article in JAMA Oncology (April 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice
Article in Frontiers in Oncology (January 2024)
First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study
Article in Cancers (October 2023)